Literature DB >> 16010642

Chinese herbal medicine in the treatment of chronic kidney disease.

Xiaomei Li1, Haiyan Wang.   

Abstract

Chronic kidney disease (CKD) is a worldwide public health issue with poor outcomes and high cost. There is growing evidence that some of the adverse outcomes of CKD can be prevented or delayed by early treatment using angiotensin II-converting enzyme inhibitors and angiotensin II-receptor blockers. A great amount of the world's population has been using traditional Chinese herbal medicine (TCHM) for treatment of CKD and has accumulated their experience for years. In this article, the knowledge and the therapeutic principles of traditional Chinese medicine in the treatment of CKD are briefly reviewed. The efficacy of several TCHMs, supported by either clinical evidence or experimental studies, is presented. The future direction for the study of Chinese herbal medicines in CKD is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16010642     DOI: 10.1016/j.ackd.2005.03.007

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  23 in total

1.  Timosaponin AIII mediates caspase activation and induces apoptosis through JNK1/2 pathway in human promyelocytic leukemia cells.

Authors:  Hsin-Lien Huang; Whei-Ling Chiang; Pei-Ching Hsiao; Ming-Hsien Chien; Hui-Yu Chen; Wei-Chun Weng; Ming-Ju Hsieh; Shun-Fa Yang
Journal:  Tumour Biol       Date:  2014-12-27

2.  Jian-Pi-Yi-Shen Formula Improves Adenine-Induced Chronic Kidney Disease via Regulating Tryptophan Metabolism and Aryl Hydrocarbon Receptor Signaling.

Authors:  Xinhui Liu; Ruyu Deng; Yulian Chen; Shiying Huang; Jiandong Lu; Lin Zheng; Guoliang Xiong; Shunmin Li
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

3.  Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cells.

Authors:  Ming-Ju Hsieh; Chiao-Wen Lin; Shun-Fa Yang; Mu-Kuan Chen; Hui-Ling Chiou
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

4.  Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy.

Authors:  L Q Meng; J W Tang; Y Wang; J R Zhao; M Y Shang; M Zhang; S Y Liu; L Qu; S Q Cai; X M Li
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

5.  Shen-Kang protects 5/6 nephrectomized rats against renal injury by reducing oxidative stress through the MAPK signaling pathways.

Authors:  Meiyou Liu; Jisoo Park; Xiaoxiao Wu; Yuwen Li; Quangdon Tran; Kisun Mun; Yongjin Lee; Gang Min Hur; Aidong Wen; Jongsun Park
Journal:  Int J Mol Med       Date:  2015-08-26       Impact factor: 4.101

6.  Glabridin mediate caspases activation and induces apoptosis through JNK1/2 and p38 MAPK pathway in human promyelocytic leukemia cells.

Authors:  Hsin-Lien Huang; Ming-Ju Hsieh; Ming-Hsien Chien; Hui-Yu Chen; Shun-Fa Yang; Pei-Ching Hsiao
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

Review 7.  The Efficacy of Shen Shuaining Capsule on Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Shanshan Wang; Jinfeng Zhang; Ming Guo; Xiaobo Lian; Miaomiao Sun; Lizhong Guo
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-14       Impact factor: 2.629

8.  Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis.

Authors:  Zhi-Hao Zhang; Feng Wei; Nosratola D Vaziri; Xian-Long Cheng; Xu Bai; Rui-Chao Lin; Ying-Yong Zhao
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

9.  A network pharmacology approach to understanding the mechanisms of action of traditional medicine: Bushenhuoxue formula for treatment of chronic kidney disease.

Authors:  Shao-hua Shi; Yue-piao Cai; Xiao-jun Cai; Xiao-yong Zheng; Dong-sheng Cao; Fa-qing Ye; Zheng Xiang
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

Review 10.  Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases.

Authors:  Yifei Zhong; Yueyi Deng; Yiping Chen; Peter Y Chuang; John Cijiang He
Journal:  Kidney Int       Date:  2013-07-17       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.